Oral Anticoagulants after Heart Transplantation-Comparison between Vitamin K Antagonists and Direct Oral Anticoagulants.

Fabrice F DarcheLisa C FabriciusMatthias HelmschrottAnn-Kathrin RahmPhilipp EhlermannTom BrucknerWiebke SommerGregor WarneckeNorbert FreyRasmus Rivinius

Published in: Journal of clinical medicine (2023)

DOACs were comparable to VKAs concerning the risk of ischemic stroke, thromboembolic events, or OAC-related death but were associated with significantly fewer bleeding complications in HTX recipients.

Keyphrases

atrial fibrillation
direct oral anticoagulants
oral anticoagulants
risk factors